Results 1 to 10 of about 151,741 (352)

Oestrogen as a calcium channel blocker [PDF]

European Heart Journal, 1996
This paper reviews the evidence for calcium-antagonist properties of oestrogen which may offer long-term protective effects on the cardiovascular system in postmenopausal women. Oestrogen has already been shown to have a beneficial effect on cholesterol metabolism and deposition, thereby inhibiting the formation of atherosclerotic plaque and coronary ...
Peter Collins, Carolyn M. Beale, Giuseppe Rosano   +2 more
openalex   +3 more sources

Calcium channel blockers revisited [PDF]

Hong Kong medical journal = Xianggang yi xue za zhi, 2002
published_or_final_versio
Cheung, BMY, Kumana, CR
core   +3 more sources

Calcium channel blockers- Induced iatrogenic gingival hyperplasia: Case series

Journal of Pharmacy and Bioallied Sciences, 2023
Hypertension rightfully termed as “Silent killer” is associated with increase in morbidity and mortality when left untreated. Calcium channel blockers are the most commonly prescribed first-line anti-hypertensive drugs in India.
G Agnes Golda Priyadarshini, Effie Edsor, S Sajesh, K Neha, Reneega Gangadhar   +4 more
doaj   +2 more sources

Telangiectasia Macularis Multiplex Acquisita and its Potential Association with Calcium Channel Blockers: A Retrospective Study of 46 Chinese Patients [PDF]

Acta Dermato-Venereologica
Telangiectasia macularis multiplex acquisita is an acquired cutaneous telangiectasis of unknown aetiology, and it lacks both effective and cost-efficient treatment.
Tian Chen, Jia-Wei Liu, Yue-Tong Qian, Xing-Yu Li, Xiao Ma, Jing-Wen Wang, Dong-Lai Ma   +6 more
doaj   +2 more sources

Are calcium channel blockers related to lung cancer? [PDF]

Drug Target Insights, 2023
Background: Calcium channel blocker (CCB) is a common antihypertensive agent for the treatment of hypertension. There are inconsistent data of an association of CCB and lung cancer in the literature.
Ratchanon Rattanathanoo, Jarin Chindaprasert, Watchara Boonsawat, Panita Limpawattana, Sittichai Khamsai, Kittisak Sawanyawisuth   +5 more
doaj   +2 more sources

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations [PDF]

Current Issues in Molecular Biology
Worldwide, hypertension is the leading risk factor for cardiovascular disease and death. An estimated 122 million people, per the American Heart Association in 2023, have been diagnosed with this common condition.
Kamryn E. Jones, Shaun L. Hayden, Hannah R. Meyer, Jillian L. Sandoz, William H. Arata, Kylie Dufrene, Corrado Ballaera, Yair Lopez Torres, Patricia Griffin, Adam M. Kaye, Sahar Shekoohi, Alan D. Kaye   +11 more
doaj   +2 more sources

The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study. [PDF]

Clin Rheumatol, 2023
Ross L, Hansen D, Maltez N, Morrisroe K, Kumar K, Walker J, Stevens W, Sahhar J, Ngian GS, Host L, Nikpour M, Proudman S.   +11 more
europepmc   +3 more sources

Basic Science and Pathogenesis. [PDF]

Alzheimers Dement
Kalra N.
europepmc   +3 more sources

The role of calcium channel blockers in wound healing [PDF]

Iranian Journal of Basic Medical Sciences, 2018
Wound healing is a natural response to restore the injured tissue to normal. Wound healing is also complicated process involving different cellular, molecular and biochemical mechanisms and various types of cytokines and growth factors.
Hoda Mojiri-Forushani
doaj   +1 more source

Renoprotective effect of calcium channel blockers [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2009
The advancing chronic renal failure is at most the consequence of secondary haemodynamic and metabolic factors as intraglomerular hypertension and glomerular hypertrophy.
Dimković Nada, Dimković Siniša
doaj   +1 more source